Thus, these data indicate that high expression of the target molecule BCL-2, in particular along with low expression of the counteracting molecule MCL-1, is related to VEN-mediated apoptosis induction in BCP-ALL cells. Here, BCL2 is linked to acute lymphoblastic leukemia.